NASDAQ: RGSRegis Corp Stock
$28.94+1.46 (+5.31%)
Updated Dec 4, 2025
RGS Price
$28.94
Fair Value Price
N/A
Market Cap
$71.78M
52 Week Low
$15.00
52 Week High
$31.50
P/E
0.54x
P/B
0.38x
P/S
0.32x
PEG
0.02x
Dividend Yield
N/A
Revenue
$223.03M
Earnings
$125.75M
Gross Margin
37.5%
Operating Margin
14.21%
Profit Margin
56.4%
Debt to Equity
2.16
Operating Cash Flow
$17M
Beta
1.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
RGS Overview
Regis Corporation franchises, owns, and operates 5,917 beauty salons in the U.S., UK, and Canada. The company also offers OpenSalon Pro, a back-office salon management system, and the Opensalon mobile application. Regis was founded in 1922 and is headquartered in Minneapolis, MN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RGS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Personal Service
Industry Rating
D
RGS
Ranked#2 of 11
Ranked#2 of 11
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $103.99 | C | |
| $5.25 | C | |
| $53.28 | C |
Be the first to know about important RGS news, forecast changes, insider trades & much more!
RGS News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RGS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RGS ($28.94) is trading below its intrinsic value of $887.88, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RGS is good value based on its earnings relative to its share price (0.54x), compared to the US market average (46.53x)
P/E vs Market Valuation
RGS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more RGS due diligence checks available for Premium users.
Valuation
RGS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0.54x
Industry
37.56x
Market
46.53x
RGS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RGS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
RGS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.38x
Industry
8.18x
RGS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
RGS price to earnings growth (PEG)
For valuing profitable companies with growth potential
RGS is good value based... subscribe to Premium to read more.
PEG Value Valuation
RGS's financial health
Profit margin
Revenue
$59.0M
Net Income
$1.4M
Profit Margin
2.3%
RGS's Earnings (EBIT) of $31.69M... subscribe to Premium to read more.
Interest Coverage Financials
RGS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$592.1M
Liabilities
$404.6M
Debt to equity
2.16
RGS's short-term liabilities ($99.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RGS's long-term liabilities ($304.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RGS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RGS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$2.3M
Investing
-$395.0k
Financing
-$1.3M
RGS's operating cash flow ($17.37M)... subscribe to Premium to read more.
Debt Coverage Financials
RGS vs Personal Service Stocks
Regis Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.